Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals

Journal of Endocrinology

Volumn 180, Issue 1, 2004, Pages 107-112

  Giltay, E J ^a,b   Toorians, A W F T ^a   Sarabjitsingh, A R ^a   de Vries, N A ^a   Gooren, L J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGZ Delfland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCOSE; INSULIN; LIPID; TESTOSTERONE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAIR LOSS; HORMONE SENSITIVITY; HUMAN; HYPOTHESIS; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE TYPE ALOPECIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SELF EVALUATION; TRANSSEXUALISM;

ADULT; ALOPECIA; ANDROGENS; BLOOD GLUCOSE; CORONARY DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INSULIN; LIPIDS; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSSEXUALISM;

EID: 0842281934     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1800107     Document Type: Article

References (30)

1. 2 cholesterol. Metabolism 43 935-939.
2. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18 774-800.
3. Elbers JMH, Giltay EJ, Teerlink T, Scheffer MA, Asscheman H, Seidell JC & Gooren LJG 2003 Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clinical Endocrinology 58 562-571.
4. Ellis JA, Stebbing M & Harrap SB 2001 Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clinical Science 100 401-404.
5. Ferriman D & Purdie AW 1979 The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clinical Endocrinology 11 291-300.
6. Ford ES, Freedman DS & Byers T 1996 Baldness and ischemic heart disease in a national sample of men. American Journal of Epidemiology 143 651-657.
7. Futterweit W, Dunaif A, Yeh HC & Kingsley P 1988 The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. Journal of the American Academy of Dermatology 19 831-836.
8. Giltay EJ & Gooren LJ 2000 Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. Journal of Clinical Endocrinology and Metabolism 85 2913-2921.
9. Glazer G 1991 Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Archives of Internal Medicine 151 1925-1933.
10. Herrera CR, D'Agostino RB, Gerstman BB, Bosco LA & Belanger AJ 1995 Baldness and coronary heart disease rates in men from the Framingham Study. American Journal of Epidemiology 142 828-833.
11. Hibberts NA, Howell AE & Randall VA 1998 Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. Journal of Endocrinology 156 59-62.
12. Hodges YK, Richer JK, Horwitz KB & Horwitz LD 1999 Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation 99 2688-2693.
13. Horton R, Pasupuletti V & Antonipillai I 1993 Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology 133 447-451.
14. Laws A & Reaven GM 1993 Insulin resistance and risk factors for coronary heart disease. Baillieres Clinical Endocrinology and Metabolism 7 1063-1078.
15. Legro RS, Kunselman AR, Demers L, Wang SC, Bentle-Lewis R & Dunaif A 2002 Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 2134-2138.
16. Lesko SM, Rosenberg L & Shapiro S 1993 A case-control study of baldness in relation to myocardial infarction in men. Journal of the American Medical Association 269 998-1003.
17. Lotufo PA, Chae CU, Ajani UA, Hennekens CH & Manson JE 2000 Male pattern baldness and coronary heart disease: the Physicians' Health Study. Archives of Internal Medicine 160 165-171.
18. Matilainen V, Koskela P & Keinanen-Kiukaanniemi S 2000 Early androgenetic alopecia as a marker of insulin resistance. Lancet 356 1165-1166.
19. Matilainen VA, Makinen PK & Keinanen-Kiukaanniemi SM 2001 Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. Journal of Cardiovascular Risk 8 147-151.
20. McGill HC Jr, Anselmo VC, Buchanan JM & Sheridan PJ 1980 The heart is a target organ for androgen. Science 207 775-777.
21. Norwood OT 1975 Male pattern baldness: classification and incidence. Southern Medical Journal 68 1359-1365.
22. Price VH 1999 Treatment of hair loss. New England Journal of Medicine 341 964-973.
23. Schnohr P, Lange P, Nyboe J, Appleyard M & Jensen G 1995 Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. American Heart Journal 130 1003-1010.
24. Signorello LB, Wuu J, Hsieh C, Tzonou A, Trichopoulos D & Mantzoros CS 1999 Hormones and hair patterning in men: a role for insulin-like growth factor I? Journal of the American Academy of Dermatology 40 200-203.
25. Trevisan M, Farinaro E, Krogh V, Jossa F, Giumetti D, Fusco G, Panico S, Mellone C, Frascatore S, Scottoni A et al. 1993 Baldness and coronary heart disease risk factors. Journal of Clinical Epidemiology 46 1213-1218.
26. van Kesteren PJ, Asscheman H, Megens JA & Gooren LJ 1997 Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology 47 337-342.
27. Vexiau P, Chaspoux C, Boudou P, Fiet J, Abramovici Y, Rueda MJ, Hardy N & Reygagne P 2000 Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Archives of Dermatological Research 292 598-604.
28. Vierhapper H, Nowotny P, Maier H & Waldhä usl W 2001 Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: determination by stable isotope/dilution and mass spectrometry. Journal of Clinical Endocrinology and Metabolism 86 5762-5764.
29. Walker PA, Berger JC, Green R, Laub DR, Reynolds CL & Wollman L 1985 Standards of care: the hormonal and surgical sex reassignment of gender dysphoric persons. Archives of Sexual Behavior 14 79-90.
30. Wild S, Pierpoint T, Jacobs H & McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Human Fertility 3 101-105.